BIT's Upcoming Events
   Group Photo

On March 23-25, 2011, BIT Life Sciences’ 3rd Annual World Vaccine Congress-2011 was jointly held with the the 4th Annual Protein and Peptide Conference, the 3rd Annual World Congress of BioSoft as well as the 3rd Annual Congress of Antibodies. The conference was supported by China Medicinal Biotech Association (CMBA), P.R. China and Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China. This year’s congress has obtained highly focus and extensive attentions throughout the world.

As the keynote speakers, Dr. Michel De Wilde, Senior Vice President of Research & Development, Sanofipasteur, Belgium; Dr. John W. Shiver, Vice President & Worldwide Basic Research Franchise Head, Vaccines. Merck & Co., Inc., USA; Dr. Rahul Singhvi, CEO & President, Novavax Inc., USA; Dr. John E. Tedstrom, President & CEO, Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria (GBC), USA and Dr. Wen Yumei, Academician, Chinese Academy of Engineering, China made excellent presentations and warmly discussed with the audiences at keynote forum.

Totally, there were more than 1500 participants from more than 56 countries and areas have attended the WCV-2011. Meanwhile, as much as 48 exhibitors from home and abroad showed their productions which had became a major attraction during the conference. Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development of vaccine.

Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing WCV-2012 which would be better and more successful than WCV-2011.

 Highlights of the Conference
  1. More than 400 presentations covering science, technology, business, economics and policy in the field of vaccines by distinguished scientists and businessmen
  2. Presentation of 200 posters and 100 exhibitions of new products and technologies to an audience of over 3000 people
  3. Five educational workshops
  4. Round table discussions to create network and marketing opportunities for your business
  5. Five workshops and 12 tracts covering a broad spectrum of vaccine research including development of vaccines for humans, but also livestock, agriculture, and aquaculture.
  6. Honorary forum for a remarkable scientist and his life-long achievements
  7. Career fairs, poster sessions, expositions for both academia and industries.
  8. Tours to famous regions of China including Beijing, Xi’an, Hangzhou, Guilin and Kunming.

Keynote Speakers



Dr. Michel De Wilde, Senior Vice President of Research & Development, Sanofipasteur, Belgium



Dr. John W. Shiver, Vice President & Worldwide Basic Research Franchise Head, Vaccines. Merck & Co., Inc., USA



Dr. Rahul Singhvi, CEO & President, Novavax Inc., USA












  Dr. John E. Tedstrom,
President & CEO, Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria (GBC), USA
    Dr. Wen Yumei, Academician, Chinese Academy of Engineering, China        

Renowned Speakers




Dr. Nathalie Garcon,
Vice President , GSK Biologicals, USA




Dr. Peter H. Khoury,
Vice President, Global Marketing Baxter BioScience, Vaccines, USA




Dr. Oliver Kisker, Senior Vice President, Merck KGaA, Germany













Dr. Jaap Goudsmit,
Chief Scientific Officer, Crucell, The Netherlands




Dr. B. G. Rhee,
Executive Vice President, Green Cross Corporate, Korea



Dr. Jerald C. Sadoff,
Chief Medical Officer, Crucell, The Netherlands













Dr. Eluemuno. R. Blyden,
CEO, AfriVax Inc, USA



Dr. Francis E. André,
Ex-Vice President, GlaxoSmithKline Biologicals, Belgium




Dr. Frank J. Malinoski,
Chief Medical Officer, Liquidia Technologies, USA













Dr. Malcolm Thomas,
President and CEO, Arbovax, Inc., USA



Dr. Tilahun Yilma, Academician, National Academy of Sciences, USA



Dr. Mark R Alderson,
Director, Pneumococcal Vaccine Project, PATH, USA













Dr. Thomas Muster,
CEO, AVIR Green Hills Biotechnology, Austria




 Dr. Robert Lambkin-Williams,
CEO, Retroscreen Virology Limited, UK




Dr. Bernd Eisele, CEO of VPM Inc., Germany













 Dr. Richard L. Amoroso,
Director, Noetic Advanced Studies Institute, USA




Dr. Jose M. Galarza,
CEO, TechnoVax, Inc., USA



 Dr. Jeanne Novak, President and Chief Executive Officer, CBR International Corporation, USA












Dr. Tomas Jelinek, Medical Director, Berlin Centre for Travel & Tropical Medicine, Germany



Dr. John Y. Dong,
President & CEO, Division of Biodefense Vaccines, GenPhar Inc., USA


  Dr. Robert Whalen, Chief Scientific Officer, AltraVax Inc., USA

Dr. Andrew A.

CEO, InterVac, Canada




Dr. Jonathan Liu,
Director, Vaccine Development, MedImmune Inc, USA


Dr. Richard I. Walker,
Director, Vaccine Development Global Program, PATH, USA












Dr. Daniel Scherman,
Director, National Scientific Research Center, France




 Dr. Bram Palache,
Director, Influenza Vaccines, Solvay Biologicals, The Netherlands



Dr. Charles E. Richardson, Executive Vice President, LigoCyte Pharmaceuticals Inc., USA












Dr. Pierre Tiollais,
Director, Institut Pasteur, France



Dr. Doug Given, Investment Partner, Bay City Capital, USA


Dr. Scott E. LaPatra,
Director, Clear Springs Foods, Inc., USA












Dr. Yasutaka Hoshino,
Chief, National Institutes of Health, USA



Dr. Macaulay Onuigbo,
Regional Director, Mayo Health System Practice-Based Research Network, USA



Dr. Mai-Britt Zocca, CEO & CSO, DanDrit Biotech A/S, Denmark












Dr. Nikolai Petrovsky, Director, Vaxine Pty Ltd, Australia



Dr. Harm J. Geerligs,
R & D Manager, Pfizer Animal Health, The Netherlands



Dr. J. Tyler Martin,
Chief Medical Officer & President, Dynavax Technologies Corporation, USA












Dr. Alton Boynton, CEO & President, Northwest Biotherapeutics Inc., USA



Dr. Jan Jezek,
CSO, Arecor Ltd, UK



Dr. Jo-Anne R. Dillon, Professor & Dean, University of Saskatchewan, Canada












Dr. Robert W. Gracy,
Vice President, The University of Texas at San Antonio, USA



Dr. Frank Y. Tung, CEO, GeneCure Biotechnologies, USA



Dr. Wellington Sun, Director, Division of Vaccines & Related Products Applications, FDA, USA

 Programmed Chapters at a Glance
Chapter 1: Global Immunization Plans and Alliances
-Stop Fetal Diseases and Take Actions
Chapter 2: Breaking Research and Tech Development in Modern Vaccinology
-New Thoughts, New Wave, New Methods and New Gateway for Success
Chapter 4: Livestock/Veterinary/
Aquaculture Vaccines

-Maintain a Healthier Animal Kingdom by Immunization
Chapter 5: Vectors, Adjuvants, and Vaccine Delivery Technology
Smart Assistants to the Effective Vaccinations
Chapter 6: Animal Models and Clinical Trials
-Safety and Efficacy Security using Right Models and Assessments
Chapter 7: Vaccine Bioprocess,
Production and Manufacturing

-Meet the Demand on Safe and
Productive Green Bio-Industry

Chapter 8: Public Health, Economics, Safety/Ethic and Policy of Vaccination
-Understanding the Legislative, Social,
Ethic and Public Health Systems

Chapter 9:Special Symposium: Young Investigator Research
-Hope, Faith, Followers and the Future
Social Events: Art Performance and Tech-tour
-Surfing On a 5000 Year-wide Ocean of Chinese Culture

  Background of WCV-2010

BIT’s 2nd Annual World Congress of Vaccine (WCV-2010) was successfully held March 23-25, 2010in Beijing, China with the theme “Next Generation of Vaccines.” WCV-2010 was held together with the wnd Annual Congress of Antibodies (ICA-2010). These 2 conferences brought together more than 1000 participants and 100 exhibitors from 46 countries. Dr. Roy Curtiss III,Academician, United States National Academy of Sciences, USA; Dr. John B Robbins, Senior Investigator, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Dexian Zheng, Vice President, Chinese Society for Immunolgy, China; Dr. Jeffrey Almond, Vice President, Global Research and External Research and Development, Sanofi-Pasteur, France; Dr. Jean-Paul Prieels, Senior Vice President, Research & Development, GlaxoSmithKline Biologicals, Belgium; and Dr. Peter H. Khoury, Vice President, Global Marketing Baxter BioScience, Vaccines, USA;  gave wonderful keynote speeches during the conference.More...


   Exhibition and Poster

WCV-2011 provides an ideal platform to showcase your new technologies and products in China. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.


Why Reserve a Booth at WCV-2011

Meet international leaders in the field of antibody science

  and technology

Meet key decision makers from around the world

Explore business opportunities in China and beyond

Spotlight your technology and its commercial application

Take advantage of the targeted audience at the conference
  and network in the exhibition hall


Hosting Organization

Information Research Center of International Talent, SAFEA
China Medicinal
Biotech Association

Operating Organization


BIT Life Sciences, Inc.

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Supporting Organization

China Council for the Promotion of
International Trade
Dalian Sub-Council

Regional Marketing Representative

Australian BioBest
Biotechnology Service



Organization Participated


Arbovax, Inc., USA
Retroscreen Virology Limited, UK
VPM Inc., Germany
Vaccine Development, USA
University of Tokyo, Japan
Vaxiam, USA
Center for Computation Medicine and
Biology (CCMB), USA
University of Michigan, USA
University of Medicine and Pharmacy, Romania
Department of Medical Microbiology, Canada
Scott-Ritchey Research Center, USA
Qassim University, Saudi Arabia
Fraunhofer USA Center for Molecular Biotechnology, USA
Laboratory of Pharmacology and Chemical Genetics, INSERM, France
Norfolk State University, USA
Peking Union Medical College and Chinese Academy of Medical Sciences, China
Kansas State University, USA
Aldevron LLC, USA
National Research Council Canada, Canada
Wistar Institute, USA
Mashhad University of Medical Sciences, Iran
Liquidia Technologies, Research Triangle Park, USA
Virginia-Maryland Regional College of Veterinary Medicine, USA
VIDO/InterVac, Canada
BioReliance Ltd. UK
National Veterinary Institute, Norway
Clear Springs Foods, Inc., USA
EpiVet Ltd, UK
Nippon Institute for Biological Science, Japan
Institute for Animal Health, UK
Biovet Pvt Ltd, India
Irish Equine Centre, Ireland
Prionics Lelystad BV, The Netherlands
National Institute of Allergy and Infectious Disease (NIAID), USA
Lake Erie College of Osteopathic Medicine School of Pharmacy, USA
Bio Farma, Jl. Pasteur, Indonesia
Dana-Farber Cancer Institute, USA
AfriVax Inc., USA
Norfolk State University, USA
University of Pennsylvania, USA
SRI International, Canada
University of Georgia, USA
BioReliance Ltd. UK
Institute for Animal Health, UK
New York University, USA
Prionics Lelystad BV, The Netherlands
University of Sydney, Australia
Kenyatta University, Kenya
Shenzhen Polytechnic, China
Animal Health Diagnostic Center, USA
University of Illinois, USA
Aarhus University Hospital, Denmark
Uppsala University Hospital, Sweden
The World Hepatitis Alliance, UK
Mayo Health System Practice-Based Research Network, USA
Federal University of Goias, Brazil
Azienda Ospedaliero Universitaria Pisana, Italy
Walter Reed/ AFRIMS Research Unit, Nepal
Center for Genetic Engineering and Biotecnology, Cuba
Deutsches Krebsforschungszentrum(DKFZ), Germany
University Hospital Antwerpen, Belgium
Uppsala University, Sweden
University Konstanz, Germany
Vanderbilt University Medical Center, USA
Kitasato Institute, Japan
University of Calgary, Canada
World Association of Perinatal Medicine (WAPM), Spain
Kuwait University, Kuwait
Adelaide Research Centre for Infectious Diseases, Australia
King Saud University, Saudi Arabia
Ministry of Public Health, Thailand
U. S. Food and Drug Administration, USA
Columbia University College of Physicians and Surgeons, USA
University of New South Wales Sydney, Australia
VU University, The Netherlands
Pfizer Animal Health, The Netherlands
Bar-Ilan University, Israel
Albert Einstein College of Medicine, USA
Booz Allen Hamilton, USA
Institute of Microbial Technology, India
International Centre for Genetic Engineering and Biotechnology, India
Centenary Institute, Australia
Huazhong University of Science Technology, China
University of Linkoping, Sweden
National Institutes of Health, USA
Tufts University, USA
National Medical Centre SXXI, Mexico
University of Cambridge, UK
University Hospital of Sahloul, Tunisia
KK Women’s and Children’s Hospital, Singapore
University of Säo Paulo, Brazil
University of Saskatchewan, Canada
Technical University Munich, Germany
University of Pennsylvania, USA
College of Medicine at Rockford, USA
Chinese Academy of Agricultural Sciences, China
Novartis Vaccines and Diagnostics, Italy
Institute of Experimental Medicine Russian Academy of Medical Sciences, Russia
Emory University School of Medicine, USA
University of The West Indies, Trinidad and Tobago
University of California San Francisco, USA
National Institute for Health and Welfare, Finland
University of Cincinnati Children's Hospital, USA
Public Health Agency, Canada
Lakehead University, Canada
International AIDS Vaccine Initiative, USA
Canadian Network for Vaccines and Immunotherapeutic, Canada
UCSF School of Medicine, USA
University of Illinois at Chicago, USA
University of Barcelona, Spain
National Cancer Institute, USA
Harvard School of Public Health, USA
Center for Cancer Research Nanobiology Program, USA
Faculte de Pharmacie, France
Theraclone Sciences, USA
Antagen Biosciences, Inc., USA
University of North Carolina, USA
University of Washington, USA
Medical University of Vienna, Austria
University of Hawaii, USA
GeneCure Biotechnologies, USA
National Cancer Institute at Frederick, USA
Texas Tech University Health Sciences Center, Germany
University of Missouri-Columbia, USA
University of Cape Town, South Africa
Institute of Immunology, Russia
Bundelkhand University, India
Emory University School of Medicine, USA
University of Pittsburgh, USA
Ghent University, Belgium
Institute of Epidemiology, Disease Control Research (IEDCR), Bangladesh
Protein Sciences Corporation, USA
National Health Research Institutes, Taiwan
Vaxine Pty Ltd, Australia
Delhi Medical Council, India
Royal Veterinary College, UK
National Research Council (CONICET), Argentina
Plum Island Animal Disease Center, USA
Animal Health Service (GD), the Netherlands
National Institute of Allergy and Infectious Diseases, USA
Washington State University, USA
Prionics Lelystad BV, The Netherlands
Uppsala University, Sweden
University of Southern Queensland, USA
Institute for Animal Health, UK
University of Edinburgh, UK
Nestle Research Center, USA
Michigan Nanotechnology Institute for Medicine Biological Sciences, USA
Lake Erie College of Osteopathic Medicine School of Pharmacy, USA
Alexandria University, Egypt
Gavin Herbert Eye Institute, Canada
Kenyatta University, Kenya
Vaxil BioTherapeutics Ltd, Israel
Novavax Inc., USA
Mayo Health System Practice-Based Research Network, USA
Deutsches Krebs Forschungs Zentrum(DKFZ), Germany
University of Washington, USA
Division of Vaccines Related Products Applications, FDA, USA
GenPhar Inc., USA
World Association of Perinatal Medicine (WAPM), Spain
Pneumococcal Vaccine Project, PATH, USA
Department of Microbiology Infectious Diseases, Canada
Partec Essential Healthcare, Germany
Luton and Dunstable Hospital, UK
Vaccine Development Global Program, PATH, USA
University of Illinois, USA
Novartis Vaccines and Diagnostics GmbH, Germany
Delaware State University, USA
University of Illinois at Chicago, USA
Queen Elizabeth Hospital, UK
Animal Models and Retroviral Vaccines Section, USA
Paris-Descartes University, France
Immuno Technology Section Vaccine Research Center, NIH, USA
Theraclone Sciences, Inc., USA
Vaccine Research Center, NIAID/NIH, USA
University of Veterinary Medicine, Austria
University of Pisa, Italy
State University of New York, USA
Health Protection Agency, UK
Research Center in Oncology Nantes-Angers, France
University of Arkansas for Medical Sciences, USA
DanDrit Biotech A/S, Denmark
Northwest Biotherapeutics Inc., USA
Cedars-Sinai Medical Center, USA
University of Miami, USA
University Hospital Erlangen, Germany
Dendreon Corporation, USA
Research Institute at Nationwide Children's Hospital, USA
Brain State International Research Center, USA
Department of Diagnosis, Prevention and Treatment of Dementia, Juntendo University, Japan
World Allergy Organization, Japan
Strasbourg University Hospitals, France
University of North Texas, USA
Allergy Therapeutics Ltd, UK
Division of Pharmacotherapies and Medical Consequences of Drug Abuse, USA
Protein Sciences Corporation, USA
Pfizer Animal Health, The Netherlands
National Institute for Public Health and the Environment, The Netherlands
Indonesian Association of Physicians in AIDS Care, Indonesia
All Nations Hope AIDS Network, Canada
University of Ottawa, Canada


Media Partners

Vaccines News
Current Events Calendar
Conferences & Trade Shows

© 2009-2011 All right reserved for BIT Conferences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629